Kinetic volume analysis on dynamic contrast-enhanced MRI of triple-negative breast cancer: associations with survival outcomes.


Journal

The British journal of radiology
ISSN: 1748-880X
Titre abrégé: Br J Radiol
Pays: England
ID NLM: 0373125

Informations de publication

Date de publication:
01 Feb 2020
Historique:
pubmed: 11 12 2019
medline: 6 2 2020
entrez: 11 12 2019
Statut: ppublish

Résumé

To evaluate the associations between computer-aided diagnosis (CAD)-generated kinetic volume parameters and survival in triple-negative breast cancer (TNBC) patients. 40 patients with TNBC who underwent pre-operative MRI between March 2008 and March 2014 were included. We analyzed CAD-generated parameters on dynamic contrast-enhanced MRI, visual MRI assessment, and histopathological data. Cox proportional hazards models were used to determine associations with survival outcomes. 12 of the 40 (30.0%) patients experienced recurrence and 7 died of breast cancer after a median follow-up of 73.6 months. In multivariate analysis, higher percentage volume (%V) with more than 200% initial enhancement rate correlated with worse disease-specific survival (hazard ratio, 1.12; 95% confidence interval, 1.02-1.22; CAD-generated kinetic volume parameters may correlate with survival in TNBC patients. Further study would be necessary to validate our results on larger cohorts. CAD generated kinetic volume parameters on breast MRI can predict recurrence and survival outcome of patients in TNBC. Varying the enhancement threshold improved the predictive performance of CAD generated kinetic volume parameter.

Identifiants

pubmed: 31821036
doi: 10.1259/bjr.20190712
pmc: PMC7055451
doi:

Substances chimiques

Contrast Media 0

Types de publication

Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

20190712

Références

J Clin Oncol. 2012 May 20;30(15):1796-804
pubmed: 22508812
J Magn Reson Imaging. 2014 Aug;40(2):476-82
pubmed: 24347097
Anticancer Res. 2013 Jun;33(6):2737-42
pubmed: 23749934
Radiology. 2013 Nov;269(2):354-61
pubmed: 23878283
Breast Cancer. 2015 Jan;22(1):66-70
pubmed: 25336185
Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4429-34
pubmed: 17671126
J Magn Reson Imaging. 2018 Mar;47(3):760-766
pubmed: 28675570
J Magn Reson Imaging. 2013 Jan;37(1):146-55
pubmed: 23011784
Breast Cancer. 2019 Jan;26(1):113-124
pubmed: 30069785
J Magn Reson Imaging. 2015 Oct;42(4):920-4
pubmed: 25758675
Am Soc Clin Oncol Educ Book. 2014;:e32-6
pubmed: 24857120
J Clin Oncol. 2007 Jan 1;25(1):118-45
pubmed: 17159189
Cancer Res. 2004 May 1;64(9):2941-55
pubmed: 15126324
AJR Am J Roentgenol. 2009 Sep;193(3):832-9
pubmed: 19696299
Oncologist. 2000;5 Suppl 1:37-44
pubmed: 10804090
Radiology. 2016 Apr;279(1):44-55
pubmed: 26624971
J Clin Invest. 2011 Oct;121(10):3804-9
pubmed: 21965337
Breast Cancer Res Treat. 2013 Jun;139(2):371-9
pubmed: 23709090
Technol Cancer Res Treat. 2005 Feb;4(1):49-53
pubmed: 15649087
Cancers (Basel). 2014 Jun 27;6(3):1351-62
pubmed: 24978437
J Magn Reson Imaging. 2012 Jul;36(1):145-51
pubmed: 22392859
J Clin Oncol. 2014 Sep 20;32(27):2959-66
pubmed: 25071121
Breast Cancer Res Treat. 2019 Jan;173(1):55-64
pubmed: 30302588
Br J Radiol. 2019 May;92(1097):20181032
pubmed: 30835501
AJR Am J Roentgenol. 2017 Mar;208(3):687-694
pubmed: 28004976
Eur J Radiol. 2012 May;81(5):863-7
pubmed: 21398061
Breast Cancer Res Treat. 2014 Dec;148(3):467-76
pubmed: 25361613
PLoS One. 2018 Apr 12;13(4):e0195756
pubmed: 29649266
J Magn Reson Imaging. 2017 Oct;46(4):1037-1044
pubmed: 28370761
Breast Cancer. 2014 Nov;21(6):684-92
pubmed: 23341125
Med Phys. 2004 May;31(5):1076-82
pubmed: 15191295
Breast Cancer Res Treat. 2011 Feb;125(3):687-96
pubmed: 20361254
Eur Radiol. 2011 Jul;21(7):1364-73
pubmed: 21258931
Eur Radiol. 2015 Apr;25(4):1097-106
pubmed: 25424563
Radiology. 2016 Nov;281(2):392-400
pubmed: 27195438
Breast Cancer Res Treat. 1995;36(2):193-204
pubmed: 8534867
Curr Opin Oncol. 2011 Nov;23(6):566-77
pubmed: 21986848
J Clin Oncol. 2010 Jun 1;28(16):2784-95
pubmed: 20404251
Breast Cancer Res Treat. 2011 Nov;130(2):477-87
pubmed: 21837479
J Clin Oncol. 2008 Mar 10;26(8):1275-81
pubmed: 18250347
Magn Reson Imaging. 2016 Jan;34(1):60-5
pubmed: 26234500
J Clin Oncol. 2011 Jul 1;29(19):2628-34
pubmed: 21606433
Ann Surg Oncol. 2014 Jul;21(7):2165-71
pubmed: 24558065
PLoS One. 2016 Feb 17;11(2):e0142047
pubmed: 26886725
Radiology. 2017 Jul;284(1):45-54
pubmed: 28253106
Med Oncol. 2013 Mar;30(1):388
pubmed: 23292831
Eur J Surg Oncol. 2012 Apr;38(4):307-13
pubmed: 22264965

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH